How are Authorized Generics brought to market?
Authorized Generics can be brought to the marketplace a number of ways: three of the most common are identified below: • Brand companies establish agreements with private label marketing and distribution companies to market and distribute Authorized Generic products. This type of agreement usually results in two generics competing in the marketplace. • Brand pharmaceutical companies can establish subsidiaries to market Authorized Generics of their own brands. Several companies have launched Authorized Generics this way, but some have abandoned this approach for other options. This usually results in two generics competing in the marketplace. • Brand companies establish agreements (oftentimes a result of a patent challenge settlement) with a generic drug manufacturer to permit them to offer the Authorized Generic product until the generic company gets its ANDA approval. Once the ANDA is approved, the generic company stops offering the authorized generic. This strategy generally results
Related Questions
- Why do generics suffer more than originator products from the lack of a European single market in pharmaceuticals?
- Hasn’t legislation been recently introduced to prohibit Authorized Generics during the 180-day exclusivity period?
- Are Authorized Generics only offered by brand companies with generic subsidiaries?
